In one paragraphArticle in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
David Rodriguez-TemporalDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-1299-3110 Mark Gutiérrez-ParejaClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain.ORCID 0009-0004-0456-8426 Garrett G GordyDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Ellen M NahkalaDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Belén Rodríguez-SánchezClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain.
Robin PatelDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6344-4141 Funding
Instituto de Salud Carlos III CD22-00014Instituto de Salud Carlos III PI23/01288Intramural predoctoral contract, IISGM 2024Intramural project, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM) 2023-II-PI-02National Institute of Allergy and Infectious Diseases of the National Institutes of Health UM1AI104681
6 · The paper itselfAbstract
The increasing prevalence of carbapenem-resistant
Indexed as
Bacterial Proteinsbeta-LactamasesKlebsiella InfectionsKlebsiella pneumoniaeMachine LearningSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationEnsemble LearningHumansSensitivity and SpecificityBacterial Proteinsbeta-LactamasescarbapenemasecarbapenemaseKlebsiella pneumoniaeKPCmachine learningMALDI-TOF
Identifiers
PMID41910330
PMCPMC13170361
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390